BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 3916193)

  • 1. Suppression of carcinogenesis by retinoids: interactions with peptide growth factors and their receptors as a key mechanism.
    Sporn MB; Roberts AB
    Princess Takamatsu Symp; 1985; 16():149-58. PubMed ID: 3916193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth factors and cancer.
    Goustin AS; Leof EB; Shipley GD; Moses HL
    Cancer Res; 1986 Mar; 46(3):1015-29. PubMed ID: 3002607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anchorage-independent growth of synoviocytes from arthritic and normal joints. Stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-beta and retinoids.
    Lafyatis R; Remmers EF; Roberts AB; Yocum DE; Sporn MB; Wilder RL
    J Clin Invest; 1989 Apr; 83(4):1267-76. PubMed ID: 2784799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of action of retinoids.
    Sporn MB; Roberts AB; Roche NS; Kagechika H; Shudo K
    J Am Acad Dermatol; 1986 Oct; 15(4 Pt 2):756-64. PubMed ID: 3021829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoids potentiate transforming growth factor-beta activity in bovine endothelial cells through up-regulating the expression of transforming growth factor-beta receptors.
    Yoshizawa M; Miyazaki H; Kojima S
    J Cell Physiol; 1998 Sep; 176(3):565-73. PubMed ID: 9699509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoic acid differentially affects platelet-derived growth factor and epidermal growth factor-regulated cell growth of mouse osteoblast-like cells.
    Tsukamoto T; Matsui T; Takaishi T; Ito M; Fukase M; Chihara K
    Cell Growth Differ; 1994 Feb; 5(2):207-12. PubMed ID: 8180134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth factors and their action in vivo and in vitro.
    Gospodarowicz D
    J Pathol; 1983 Nov; 141(3):201-33. PubMed ID: 6319652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transformation-related growth factors and their receptors.
    Bregman MD; Sipes NJ
    Int J Cell Cloning; 1986 Jul; 4(4):224-36. PubMed ID: 3018097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of squamous cell carcinoma growth and differentiation by retinoids.
    Lotan R
    Cancer Res; 1994 Apr; 54(7 Suppl):1987s-1990s. PubMed ID: 8137325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Regulation of cell growth by retinoids and gene expression].
    Hashimoto Y; Kagechika H; Kawachi E; Shudo K
    Gan To Kagaku Ryoho; 1986 Dec; 13(12):3392-400. PubMed ID: 3024578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene.
    Liu J; Spence MJ; Wallace PM; Forcier K; Hellström I; Vestal RE
    Cell Growth Differ; 1997 Jun; 8(6):667-76. PubMed ID: 9186000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of effective retinoids for inhibiting growth and inducing apoptosis in bladder cancer cells.
    Zou C; Liebert M; Zou C; Grossman HB; Lotan R
    J Urol; 2001 Mar; 165(3):986-92. PubMed ID: 11176527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibition of the anchorage-independent growth of myc-transfected fibroblasts by retinoic acid.
    Roberts AB; Roche NS; Sporn MB
    Nature; 1985 May 16-22; 315(6016):237-9. PubMed ID: 2987698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flat revertants derived from Kirsten murine sarcoma virus-transformed cells produce transforming growth factors.
    Salomon DS; Zwiebel JA; Noda M; Bassin RH
    J Cell Physiol; 1984 Oct; 121(1):22-30. PubMed ID: 6090475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoid-induced suppression of squamous cell differentiation in human oral squamous cell carcinoma xenografts (line 1483) in athymic nude mice.
    Shalinsky DR; Bischoff ED; Gregory ML; Gottardis MM; Hayes JS; Lamph WW; Heyman RA; Shirley MA; Cooke TA; Davies PJ
    Cancer Res; 1995 Jul; 55(14):3183-91. PubMed ID: 7541715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells.
    Sun SY; Yue P; Mao L; Dawson MI; Shroot B; Lamph WW; Heyman RA; Chandraratna RA; Shudo K; Hong WK; Lotan R
    Clin Cancer Res; 2000 Apr; 6(4):1563-73. PubMed ID: 10778990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abrogation of transforming growth factor-alpha/epidermal growth factor receptor autocrine signaling by an RXR-selective retinoid (LGD1069, Targretin) in head and neck cancer cell lines.
    Song JI; Lango MN; Hwang JD; Drenning SD; Zeng Q; Lamph WW; Grandis JR
    Cancer Res; 2001 Aug; 61(15):5919-25. PubMed ID: 11479234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoid X receptor-specific retinoids inhibit the ability of retinoic acid receptor-specific retinoids to increase the level of insulin-like growth factor binding protein-3 in human ectocervical epithelial cells.
    Hembree JR; Agarwal C; Beard RL; Chandraratna RA; Eckert R
    Cancer Res; 1996 Apr; 56(8):1794-9. PubMed ID: 8620495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tenascin-C induction by the diffusible factor epidermal growth factor in stromal-epithelial interactions.
    Sakai T; Ohta M; Furukawa Y; Saga Y; Aizawa S; Kawakatsu H; Saito M
    J Cell Physiol; 1995 Oct; 165(1):18-29. PubMed ID: 7559800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of AIDS-Kaposi's sarcoma cell proliferation following retinoic acid receptor activation.
    Guo WX; Gill PS; Antakly T
    Cancer Res; 1995 Feb; 55(4):823-9. PubMed ID: 7850796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.